Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Freedman

Showing results (411-420 of 453) with videos related to

Pageof 46
Sort By:
Molecular Pharmacology|June 19, 2007
Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial functionLeif Erik Vinge, Kjetil W Andressen, Toril Attramadal, et al.
Human Molecular Genetics|April 28, 2010
Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studiesLisheng Zhang, Jessica J Connelly, Karsten Peppel, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitisKittichai Promrat, Glen Lutchman, Gabriel I Uwaifo, et al.
ESMO Open|July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)J Seligmann, T Koessler, M Mauer, et al.
Perfusion|May 4, 2001
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarctionM B Patel, K S Kilgore, G A Ortolano, et al.
Cardiovascular Research|June 23, 2018
Drebrin regulates angiotensin II-induced aortic remodellingLisheng Zhang, Jiao-Hui Wu, Tai-Qin Huang, et al.
Leukemia|July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaF J Giles, R T Swords, A Nagler, et al.
Physical Review Letters|October 11, 2011
New limit on time-reversal violation in beta decayH P Mumm, T E Chupp, R L Cooper, et al.
Biochemistry|May 27, 2016
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-LipoxygenaseJoshua D Deschamps, Abiola F Ogunsola, J Brian Jameson, et al.
Transfusion Medicine (Oxford, England)|September 6, 2000
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactionsB J Patterson, J Freedman, V Blanchette, et al.
Pageof 46

Showing results (411-420 of 453) with videos related to

Sort By:
Pageof 46
Molecular Pharmacology|June 19, 2007
Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial functionLeif Erik Vinge, Kjetil W Andressen, Toril Attramadal, et al.
Human Molecular Genetics|April 28, 2010
Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studiesLisheng Zhang, Jessica J Connelly, Karsten Peppel, et al.
Hepatology (Baltimore, Md.)|January 31, 2004
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitisKittichai Promrat, Glen Lutchman, Gabriel I Uwaifo, et al.
ESMO Open|July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)J Seligmann, T Koessler, M Mauer, et al.
Perfusion|May 4, 2001
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarctionM B Patel, K S Kilgore, G A Ortolano, et al.
Cardiovascular Research|June 23, 2018
Drebrin regulates angiotensin II-induced aortic remodellingLisheng Zhang, Jiao-Hui Wu, Tai-Qin Huang, et al.
Leukemia|July 10, 2012
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaF J Giles, R T Swords, A Nagler, et al.
Physical Review Letters|October 11, 2011
New limit on time-reversal violation in beta decayH P Mumm, T E Chupp, R L Cooper, et al.
Biochemistry|May 27, 2016
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-LipoxygenaseJoshua D Deschamps, Abiola F Ogunsola, J Brian Jameson, et al.
Transfusion Medicine (Oxford, England)|September 6, 2000
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactionsB J Patterson, J Freedman, V Blanchette, et al.
Pageof 46